PTEN and cancer: For instance, phosphatase and tensin homologue (PTEN)-dependent and -independent tumor suppressor mechanisms have been identified using a panel of melanoma cell-lines [1], and genetic markers of sensitivity to the anti-cancer drug, trastuzumab (HerceptinTM) have been delineated using a panel of breast cancer cell-lines [2].